Recent advances in cancer care continue to provide promise for patients. Researchers are actively exploring cutting-edge approaches, including immunotherapy , targeted therapies , and personalized approaches. A key study published this week showcases the potential of a emerging drug in combating late-stage non-small cell lung cancer . Furthermore,